NAT paper and Pre Clinical Data/Safety and ASO design
February 13 - Annemieke Aartsma-Rus, Dutch Center for RNA Therapeutics - “The most important aspects of the guidelines for N=1 exon...
top of page
Who We Are
N=1 Collaborative
Today, individualized medicines are possible.
We are on a mission to make them safe and rapidly accessible to patients worldwide.
Our Story
What started as a race against time for one little girl has turned into a movement that could help solve the global health crisis of rare genetic diseases.
Our Work
We are advancing critical steps in the development of individualized medicines, keeping the sharing of knowledge, data, safety and experience at the core.
Who We Are
We are a group of internationally acclaimed doctors, researchers, patients and companies from across the globe who are committed to expanding the field of individualized medicine.
News & Updates
bottom of page